Shaun Kirkpatrick - Profile and Investment Details

Investor Profile

Shaun Kirkpatrick is a Venture Capital based in Tucson, Arizona, United States with a diverse investment portfolio that includes companies such as Q'Apel Medical, Cantex Pharmaceuticals, Flinn Foundation, OrthAlign, Providence Medical Technology, ClearFlow, Particle Dynamics, Critical Path Institute (C-Path)Thomas R. Brown Foundations, Esperance Pharmaceuticals, Research Corporation Technologies, Inc., APT Pharmaceuticals, Alimmune, LLC, Cylene Pharmaceuticals, Dispersol Technologies, seqWell, Rubicon Genomics, CyMedica, Pheon Therapeutics, Halo Labs, Bioinformatics, . Over time, Shaun Kirkpatrick has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Shaun Kirkpatrick is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Life Science, Engineering, Analytics, Manufacturing, Biotechnology, Drug Development, Market Research, Genomics, Research, Parking, Consulting, Health Diagnostics, Regulatory Compliance, Data Management, Medical, B2B, Therapeutics, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Shaun Kirkpatrick, as their portfolio suggests a familiarity and interest in this area.

Understanding Shaun Kirkpatrick’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.